Global Pertussis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Summary
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
According to APO Research, The global Pertussis Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Pertussis Vaccine include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics and Chengdu Institute of Biological Products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Pertussis Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pertussis Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Pertussis Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pertussis Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pertussis Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pertussis Vaccine sales, projected growth trends, production technology, application and end-user industry.
Pertussis Vaccine segment by Company
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pertussis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pertussis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pertussis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pertussis Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pertussis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pertussis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
According to APO Research, The global Pertussis Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Pertussis Vaccine include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics and Chengdu Institute of Biological Products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Pertussis Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pertussis Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Pertussis Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pertussis Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pertussis Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pertussis Vaccine sales, projected growth trends, production technology, application and end-user industry.
Pertussis Vaccine segment by Company
- Sanofi Pasteur
- GSK
- Mitsubishi Tanabe Pharma
- Wuhan Institute of Biological Products
- Walvax Biotechnology
- Minhai Biotechnology
- KM Biologics
- Chengdu Institute of Biological Products
- Whole-cell Vaccines
- Acellular Vaccines
- 12 Months Below
- 12 Months Above
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pertussis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pertussis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pertussis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pertussis Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pertussis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pertussis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Pertussis Vaccine Market Size, 2019 VS 2023 VS 2030
1.3 Global Pertussis Vaccine Market Size Estimates and Forecasts (2019-2030)
1.4 Global Pertussis Vaccine Sales Estimates and Forecasts (2019-2030)
1.5 Global Pertussis Vaccine Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL PERTUSSIS VACCINE MARKET DYNAMICS
2.1 Pertussis Vaccine Industry Trends
2.2 Pertussis Vaccine Industry Drivers
2.3 Pertussis Vaccine Industry Opportunities and Challenges
2.4 Pertussis Vaccine Industry Restraints
3 PERTUSSIS VACCINE MARKET BY MANUFACTURERS
3.1 Global Pertussis Vaccine Revenue by Manufacturers (2019-2024)
3.2 Global Pertussis Vaccine Sales by Manufacturers (2019-2024)
3.3 Global Pertussis Vaccine Average Sales Price by Manufacturers (2019-2024)
3.4 Global Pertussis Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Pertussis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Pertussis Vaccine Manufacturers, Product Type & Application
3.7 Global Pertussis Vaccine Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Pertussis Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Pertussis Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Pertussis Vaccine Tier 1, Tier 2, and Tier
4 PERTUSSIS VACCINE MARKET BY TYPE
4.1 Pertussis Vaccine Type Introduction
4.1.1 Whole-cell Vaccines
4.1.2 Acellular Vaccines
4.2 Global Pertussis Vaccine Sales by Type
4.2.1 Global Pertussis Vaccine Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Pertussis Vaccine Sales by Type (2019-2030)
4.2.3 Global Pertussis Vaccine Sales Market Share by Type (2019-2030)
4.3 Global Pertussis Vaccine Revenue by Type
4.3.1 Global Pertussis Vaccine Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Pertussis Vaccine Revenue by Type (2019-2030)
4.3.3 Global Pertussis Vaccine Revenue Market Share by Type (2019-2030)
5 PERTUSSIS VACCINE MARKET BY APPLICATION
5.1 Pertussis Vaccine Application Introduction
5.1.1 12 Months Below
5.1.2 12 Months Above
5.2 Global Pertussis Vaccine Sales by Application
5.2.1 Global Pertussis Vaccine Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Pertussis Vaccine Sales by Application (2019-2030)
5.2.3 Global Pertussis Vaccine Sales Market Share by Application (2019-2030)
5.3 Global Pertussis Vaccine Revenue by Application
5.3.1 Global Pertussis Vaccine Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Pertussis Vaccine Revenue by Application (2019-2030)
5.3.3 Global Pertussis Vaccine Revenue Market Share by Application (2019-2030)
6 GLOBAL PERTUSSIS VACCINE SALES BY REGION
6.1 Global Pertussis Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Pertussis Vaccine Sales by Region (2019-2030)
6.2.1 Global Pertussis Vaccine Sales by Region (2019-2024)
6.2.2 Global Pertussis Vaccine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Pertussis Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Pertussis Vaccine Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Pertussis Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Pertussis Vaccine Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Pertussis Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Pertussis Vaccine Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Pertussis Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Pertussis Vaccine Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL PERTUSSIS VACCINE REVENUE BY REGION
7.1 Global Pertussis Vaccine Revenue by Region
7.1.1 Global Pertussis Vaccine Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Pertussis Vaccine Revenue by Region (2019-2024)
7.1.3 Global Pertussis Vaccine Revenue by Region (2025-2030)
7.1.4 Global Pertussis Vaccine Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Pertussis Vaccine Revenue (2019-2030)
7.2.2 North America Pertussis Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Pertussis Vaccine Revenue (2019-2030)
7.3.2 Europe Pertussis Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Pertussis Vaccine Revenue (2019-2030)
7.4.2 Asia-Pacific Pertussis Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Pertussis Vaccine Revenue (2019-2030)
7.5.2 LAMEA Pertussis Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Sanofi Pasteur
8.1.1 Sanofi Pasteur Comapny Information
8.1.2 Sanofi Pasteur Business Overview
8.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio
8.1.5 Sanofi Pasteur Recent Developments
8.2 GSK
8.2.1 GSK Comapny Information
8.2.2 GSK Business Overview
8.2.3 GSK Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 GSK Pertussis Vaccine Product Portfolio
8.2.5 GSK Recent Developments
8.3 Mitsubishi Tanabe Pharma
8.3.1 Mitsubishi Tanabe Pharma Comapny Information
8.3.2 Mitsubishi Tanabe Pharma Business Overview
8.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
8.3.5 Mitsubishi Tanabe Pharma Recent Developments
8.4 Wuhan Institute of Biological Products
8.4.1 Wuhan Institute of Biological Products Comapny Information
8.4.2 Wuhan Institute of Biological Products Business Overview
8.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
8.4.5 Wuhan Institute of Biological Products Recent Developments
8.5 Walvax Biotechnology
8.5.1 Walvax Biotechnology Comapny Information
8.5.2 Walvax Biotechnology Business Overview
8.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio
8.5.5 Walvax Biotechnology Recent Developments
8.6 Minhai Biotechnology
8.6.1 Minhai Biotechnology Comapny Information
8.6.2 Minhai Biotechnology Business Overview
8.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio
8.6.5 Minhai Biotechnology Recent Developments
8.7 KM Biologics
8.7.1 KM Biologics Comapny Information
8.7.2 KM Biologics Business Overview
8.7.3 KM Biologics Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 KM Biologics Pertussis Vaccine Product Portfolio
8.7.5 KM Biologics Recent Developments
8.8 Chengdu Institute of Biological Products
8.8.1 Chengdu Institute of Biological Products Comapny Information
8.8.2 Chengdu Institute of Biological Products Business Overview
8.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
8.8.5 Chengdu Institute of Biological Products Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Pertussis Vaccine Value Chain Analysis
9.1.1 Pertussis Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Pertussis Vaccine Production Mode & Process
9.2 Pertussis Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Pertussis Vaccine Distributors
9.2.3 Pertussis Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Pertussis Vaccine Market Size, 2019 VS 2023 VS 2030
1.3 Global Pertussis Vaccine Market Size Estimates and Forecasts (2019-2030)
1.4 Global Pertussis Vaccine Sales Estimates and Forecasts (2019-2030)
1.5 Global Pertussis Vaccine Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL PERTUSSIS VACCINE MARKET DYNAMICS
2.1 Pertussis Vaccine Industry Trends
2.2 Pertussis Vaccine Industry Drivers
2.3 Pertussis Vaccine Industry Opportunities and Challenges
2.4 Pertussis Vaccine Industry Restraints
3 PERTUSSIS VACCINE MARKET BY MANUFACTURERS
3.1 Global Pertussis Vaccine Revenue by Manufacturers (2019-2024)
3.2 Global Pertussis Vaccine Sales by Manufacturers (2019-2024)
3.3 Global Pertussis Vaccine Average Sales Price by Manufacturers (2019-2024)
3.4 Global Pertussis Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Pertussis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Pertussis Vaccine Manufacturers, Product Type & Application
3.7 Global Pertussis Vaccine Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Pertussis Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Pertussis Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Pertussis Vaccine Tier 1, Tier 2, and Tier
4 PERTUSSIS VACCINE MARKET BY TYPE
4.1 Pertussis Vaccine Type Introduction
4.1.1 Whole-cell Vaccines
4.1.2 Acellular Vaccines
4.2 Global Pertussis Vaccine Sales by Type
4.2.1 Global Pertussis Vaccine Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Pertussis Vaccine Sales by Type (2019-2030)
4.2.3 Global Pertussis Vaccine Sales Market Share by Type (2019-2030)
4.3 Global Pertussis Vaccine Revenue by Type
4.3.1 Global Pertussis Vaccine Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Pertussis Vaccine Revenue by Type (2019-2030)
4.3.3 Global Pertussis Vaccine Revenue Market Share by Type (2019-2030)
5 PERTUSSIS VACCINE MARKET BY APPLICATION
5.1 Pertussis Vaccine Application Introduction
5.1.1 12 Months Below
5.1.2 12 Months Above
5.2 Global Pertussis Vaccine Sales by Application
5.2.1 Global Pertussis Vaccine Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Pertussis Vaccine Sales by Application (2019-2030)
5.2.3 Global Pertussis Vaccine Sales Market Share by Application (2019-2030)
5.3 Global Pertussis Vaccine Revenue by Application
5.3.1 Global Pertussis Vaccine Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Pertussis Vaccine Revenue by Application (2019-2030)
5.3.3 Global Pertussis Vaccine Revenue Market Share by Application (2019-2030)
6 GLOBAL PERTUSSIS VACCINE SALES BY REGION
6.1 Global Pertussis Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Pertussis Vaccine Sales by Region (2019-2030)
6.2.1 Global Pertussis Vaccine Sales by Region (2019-2024)
6.2.2 Global Pertussis Vaccine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Pertussis Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Pertussis Vaccine Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Pertussis Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Pertussis Vaccine Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Pertussis Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Pertussis Vaccine Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Pertussis Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Pertussis Vaccine Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL PERTUSSIS VACCINE REVENUE BY REGION
7.1 Global Pertussis Vaccine Revenue by Region
7.1.1 Global Pertussis Vaccine Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Pertussis Vaccine Revenue by Region (2019-2024)
7.1.3 Global Pertussis Vaccine Revenue by Region (2025-2030)
7.1.4 Global Pertussis Vaccine Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Pertussis Vaccine Revenue (2019-2030)
7.2.2 North America Pertussis Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Pertussis Vaccine Revenue (2019-2030)
7.3.2 Europe Pertussis Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Pertussis Vaccine Revenue (2019-2030)
7.4.2 Asia-Pacific Pertussis Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Pertussis Vaccine Revenue (2019-2030)
7.5.2 LAMEA Pertussis Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Sanofi Pasteur
8.1.1 Sanofi Pasteur Comapny Information
8.1.2 Sanofi Pasteur Business Overview
8.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio
8.1.5 Sanofi Pasteur Recent Developments
8.2 GSK
8.2.1 GSK Comapny Information
8.2.2 GSK Business Overview
8.2.3 GSK Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 GSK Pertussis Vaccine Product Portfolio
8.2.5 GSK Recent Developments
8.3 Mitsubishi Tanabe Pharma
8.3.1 Mitsubishi Tanabe Pharma Comapny Information
8.3.2 Mitsubishi Tanabe Pharma Business Overview
8.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
8.3.5 Mitsubishi Tanabe Pharma Recent Developments
8.4 Wuhan Institute of Biological Products
8.4.1 Wuhan Institute of Biological Products Comapny Information
8.4.2 Wuhan Institute of Biological Products Business Overview
8.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
8.4.5 Wuhan Institute of Biological Products Recent Developments
8.5 Walvax Biotechnology
8.5.1 Walvax Biotechnology Comapny Information
8.5.2 Walvax Biotechnology Business Overview
8.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio
8.5.5 Walvax Biotechnology Recent Developments
8.6 Minhai Biotechnology
8.6.1 Minhai Biotechnology Comapny Information
8.6.2 Minhai Biotechnology Business Overview
8.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio
8.6.5 Minhai Biotechnology Recent Developments
8.7 KM Biologics
8.7.1 KM Biologics Comapny Information
8.7.2 KM Biologics Business Overview
8.7.3 KM Biologics Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 KM Biologics Pertussis Vaccine Product Portfolio
8.7.5 KM Biologics Recent Developments
8.8 Chengdu Institute of Biological Products
8.8.1 Chengdu Institute of Biological Products Comapny Information
8.8.2 Chengdu Institute of Biological Products Business Overview
8.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
8.8.5 Chengdu Institute of Biological Products Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Pertussis Vaccine Value Chain Analysis
9.1.1 Pertussis Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Pertussis Vaccine Production Mode & Process
9.2 Pertussis Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Pertussis Vaccine Distributors
9.2.3 Pertussis Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
LIST OF TABLES
Table 1. Pertussis Vaccine Industry Trends
Table 2. Pertussis Vaccine Industry Drivers
Table 3. Pertussis Vaccine Industry Opportunities and Challenges
Table 4. Pertussis Vaccine Industry Restraints
Table 5. Global Pertussis Vaccine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Pertussis Vaccine Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Pertussis Vaccine Sales by Manufacturers (M Doses) & (2019-2024)
Table 8. Global Pertussis Vaccine Sales Market Share by Manufacturers
Table 9. Global Pertussis Vaccine Average Sales Price (USD/Doses) of Manufacturers (2019-2024)
Table 10. Global Pertussis Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Pertussis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Pertussis Vaccine Manufacturers, Product Type & Application
Table 13. Global Pertussis Vaccine Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Pertussis Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Whole-cell Vaccines
Table 17. Major Manufacturers of Acellular Vaccines
Table 18. Global Pertussis Vaccine Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 19. Global Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 20. Global Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)
Table 21. Global Pertussis Vaccine Sales Market Share by Type (2019-2024)
Table 22. Global Pertussis Vaccine Sales Market Share by Type (2025-2030)
Table 23. Global Pertussis Vaccine Revenue by Type 2019 VS 2023 VS 2030 (M Doses)
Table 24. Global Pertussis Vaccine Revenue by Type (2019-2024) & (M Doses)
Table 25. Global Pertussis Vaccine Revenue by Type (2025-2030) & (M Doses)
Table 26. Global Pertussis Vaccine Revenue Market Share by Type (2019-2024)
Table 27. Global Pertussis Vaccine Revenue Market Share by Type (2025-2030)
Table 28. Major Manufacturers of 12 Months Below
Table 29. Major Manufacturers of 12 Months Above
Table 30. Global Pertussis Vaccine Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 31. Global Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 32. Global Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)
Table 33. Global Pertussis Vaccine Sales Market Share by Application (2019-2024)
Table 34. Global Pertussis Vaccine Sales Market Share by Application (2025-2030)
Table 35. Global Pertussis Vaccine Revenue by Application 2019 VS 2023 VS 2030 (M Doses)
Table 36. Global Pertussis Vaccine Revenue by Application (2019-2024) & (M Doses)
Table 37. Global Pertussis Vaccine Revenue by Application (2025-2030) & (M Doses)
Table 38. Global Pertussis Vaccine Revenue Market Share by Application (2019-2024)
Table 39. Global Pertussis Vaccine Revenue Market Share by Application (2025-2030)
Table 40. Global Pertussis Vaccine Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 41. Global Pertussis Vaccine Sales by Region (2019-2024) & (M Doses)
Table 42. Global Pertussis Vaccine Sales Market Share by Region (2019-2024)
Table 43. Global Pertussis Vaccine Sales Forecasted by Region (2025-2030) & (M Doses)
Table 44. Global Pertussis Vaccine Sales Forecasted Market Share by Region (2025-2030)
Table 45. North America Pertussis Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 46. North America Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 47. North America Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
Table 48. Europe Pertussis Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 49. Europe Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 50. Europe Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
Table 51. Asia Pacific Pertussis Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 52. Asia Pacific Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 53. Asia Pacific Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
Table 54. LAMEA Pertussis Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 55. LAMEA Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 56. LAMEA Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
Table 57. Global Pertussis Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 58. Global Pertussis Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 59. Global Pertussis Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 60. Global Pertussis Vaccine Revenue Market Share by Region (2019-2024)
Table 61. Global Pertussis Vaccine Revenue Market Share by Region (2025-2030)
Table 62. Sanofi Pasteur Company Information
Table 63. Sanofi Pasteur Business Overview
Table 64. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 65. Sanofi Pasteur Pertussis Vaccine Product Portfolio
Table 66. Sanofi Pasteur Recent Development
Table 67. GSK Company Information
Table 68. GSK Business Overview
Table 69. GSK Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 70. GSK Pertussis Vaccine Product Portfolio
Table 71. GSK Recent Development
Table 72. Mitsubishi Tanabe Pharma Company Information
Table 73. Mitsubishi Tanabe Pharma Business Overview
Table 74. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 75. Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
Table 76. Mitsubishi Tanabe Pharma Recent Development
Table 77. Wuhan Institute of Biological Products Company Information
Table 78. Wuhan Institute of Biological Products Business Overview
Table 79. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 80. Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
Table 81. Wuhan Institute of Biological Products Recent Development
Table 82. Walvax Biotechnology Company Information
Table 83. Walvax Biotechnology Business Overview
Table 84. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 85. Walvax Biotechnology Pertussis Vaccine Product Portfolio
Table 86. Walvax Biotechnology Recent Development
Table 87. Minhai Biotechnology Company Information
Table 88. Minhai Biotechnology Business Overview
Table 89. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 90. Minhai Biotechnology Pertussis Vaccine Product Portfolio
Table 91. Minhai Biotechnology Recent Development
Table 92. KM Biologics Company Information
Table 93. KM Biologics Business Overview
Table 94. KM Biologics Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 95. KM Biologics Pertussis Vaccine Product Portfolio
Table 96. KM Biologics Recent Development
Table 97. Chengdu Institute of Biological Products Company Information
Table 98. Chengdu Institute of Biological Products Business Overview
Table 99. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 100. Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
Table 101. Chengdu Institute of Biological Products Recent Development
Table 102. Key Raw Materials
Table 103. Raw Materials Key Suppliers
Table 104. Pertussis Vaccine Distributors List
Table 105. Pertussis Vaccine Customers List
Table 106. Research Programs/Design for This Report
Table 107. Authors List of This Report
Table 108. Secondary Sources
Table 109. Primary Sources
Table 1. Pertussis Vaccine Industry Trends
Table 2. Pertussis Vaccine Industry Drivers
Table 3. Pertussis Vaccine Industry Opportunities and Challenges
Table 4. Pertussis Vaccine Industry Restraints
Table 5. Global Pertussis Vaccine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Pertussis Vaccine Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Pertussis Vaccine Sales by Manufacturers (M Doses) & (2019-2024)
Table 8. Global Pertussis Vaccine Sales Market Share by Manufacturers
Table 9. Global Pertussis Vaccine Average Sales Price (USD/Doses) of Manufacturers (2019-2024)
Table 10. Global Pertussis Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Pertussis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Pertussis Vaccine Manufacturers, Product Type & Application
Table 13. Global Pertussis Vaccine Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Pertussis Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Whole-cell Vaccines
Table 17. Major Manufacturers of Acellular Vaccines
Table 18. Global Pertussis Vaccine Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 19. Global Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 20. Global Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)
Table 21. Global Pertussis Vaccine Sales Market Share by Type (2019-2024)
Table 22. Global Pertussis Vaccine Sales Market Share by Type (2025-2030)
Table 23. Global Pertussis Vaccine Revenue by Type 2019 VS 2023 VS 2030 (M Doses)
Table 24. Global Pertussis Vaccine Revenue by Type (2019-2024) & (M Doses)
Table 25. Global Pertussis Vaccine Revenue by Type (2025-2030) & (M Doses)
Table 26. Global Pertussis Vaccine Revenue Market Share by Type (2019-2024)
Table 27. Global Pertussis Vaccine Revenue Market Share by Type (2025-2030)
Table 28. Major Manufacturers of 12 Months Below
Table 29. Major Manufacturers of 12 Months Above
Table 30. Global Pertussis Vaccine Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 31. Global Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 32. Global Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)
Table 33. Global Pertussis Vaccine Sales Market Share by Application (2019-2024)
Table 34. Global Pertussis Vaccine Sales Market Share by Application (2025-2030)
Table 35. Global Pertussis Vaccine Revenue by Application 2019 VS 2023 VS 2030 (M Doses)
Table 36. Global Pertussis Vaccine Revenue by Application (2019-2024) & (M Doses)
Table 37. Global Pertussis Vaccine Revenue by Application (2025-2030) & (M Doses)
Table 38. Global Pertussis Vaccine Revenue Market Share by Application (2019-2024)
Table 39. Global Pertussis Vaccine Revenue Market Share by Application (2025-2030)
Table 40. Global Pertussis Vaccine Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 41. Global Pertussis Vaccine Sales by Region (2019-2024) & (M Doses)
Table 42. Global Pertussis Vaccine Sales Market Share by Region (2019-2024)
Table 43. Global Pertussis Vaccine Sales Forecasted by Region (2025-2030) & (M Doses)
Table 44. Global Pertussis Vaccine Sales Forecasted Market Share by Region (2025-2030)
Table 45. North America Pertussis Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 46. North America Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 47. North America Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
Table 48. Europe Pertussis Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 49. Europe Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 50. Europe Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
Table 51. Asia Pacific Pertussis Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 52. Asia Pacific Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 53. Asia Pacific Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
Table 54. LAMEA Pertussis Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 55. LAMEA Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 56. LAMEA Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
Table 57. Global Pertussis Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 58. Global Pertussis Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 59. Global Pertussis Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 60. Global Pertussis Vaccine Revenue Market Share by Region (2019-2024)
Table 61. Global Pertussis Vaccine Revenue Market Share by Region (2025-2030)
Table 62. Sanofi Pasteur Company Information
Table 63. Sanofi Pasteur Business Overview
Table 64. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 65. Sanofi Pasteur Pertussis Vaccine Product Portfolio
Table 66. Sanofi Pasteur Recent Development
Table 67. GSK Company Information
Table 68. GSK Business Overview
Table 69. GSK Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 70. GSK Pertussis Vaccine Product Portfolio
Table 71. GSK Recent Development
Table 72. Mitsubishi Tanabe Pharma Company Information
Table 73. Mitsubishi Tanabe Pharma Business Overview
Table 74. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 75. Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
Table 76. Mitsubishi Tanabe Pharma Recent Development
Table 77. Wuhan Institute of Biological Products Company Information
Table 78. Wuhan Institute of Biological Products Business Overview
Table 79. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 80. Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
Table 81. Wuhan Institute of Biological Products Recent Development
Table 82. Walvax Biotechnology Company Information
Table 83. Walvax Biotechnology Business Overview
Table 84. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 85. Walvax Biotechnology Pertussis Vaccine Product Portfolio
Table 86. Walvax Biotechnology Recent Development
Table 87. Minhai Biotechnology Company Information
Table 88. Minhai Biotechnology Business Overview
Table 89. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 90. Minhai Biotechnology Pertussis Vaccine Product Portfolio
Table 91. Minhai Biotechnology Recent Development
Table 92. KM Biologics Company Information
Table 93. KM Biologics Business Overview
Table 94. KM Biologics Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 95. KM Biologics Pertussis Vaccine Product Portfolio
Table 96. KM Biologics Recent Development
Table 97. Chengdu Institute of Biological Products Company Information
Table 98. Chengdu Institute of Biological Products Business Overview
Table 99. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 100. Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
Table 101. Chengdu Institute of Biological Products Recent Development
Table 102. Key Raw Materials
Table 103. Raw Materials Key Suppliers
Table 104. Pertussis Vaccine Distributors List
Table 105. Pertussis Vaccine Customers List
Table 106. Research Programs/Design for This Report
Table 107. Authors List of This Report
Table 108. Secondary Sources
Table 109. Primary Sources
LIST OF FIGURES
Figure 1. Pertussis Vaccine Product Picture
Figure 2. Global Pertussis Vaccine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pertussis Vaccine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Pertussis Vaccine Sales (2019-2030) & (M Doses)
Figure 5. Global Pertussis Vaccine Average Price (USD/Doses) & (2019-2030)
Figure 6. Global Top 5 and 10 Pertussis Vaccine Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Whole-cell Vaccines Picture
Figure 9. Acellular Vaccines Picture
Figure 10. Global Pertussis Vaccine Sales by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 11. Global Pertussis Vaccine Sales Market Share 2019 VS 2023 VS 2030
Figure 12. Global Pertussis Vaccine Sales Market Share by Type (2019-2030)
Figure 13. Global Pertussis Vaccine Revenue by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 14. Global Pertussis Vaccine Revenue Market Share 2019 VS 2023 VS 2030
Figure 15. Global Pertussis Vaccine Revenue Market Share by Type (2019-2030)
Figure 16. 12 Months Below Picture
Figure 17. 12 Months Above Picture
Figure 18. Global Pertussis Vaccine Sales by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 19. Global Pertussis Vaccine Sales Market Share 2019 VS 2023 VS 2030
Figure 20. Global Pertussis Vaccine Sales Market Share by Application (2019-2030)
Figure 21. Global Pertussis Vaccine Revenue by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 22. Global Pertussis Vaccine Revenue Market Share 2019 VS 2023 VS 2030
Figure 23. Global Pertussis Vaccine Revenue Market Share by Application (2019-2030)
Figure 24. North America Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 25. North America Pertussis Vaccine Sales Market Share by Country (2019-2030)
Figure 26. U.S. Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 27. Canada Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 28. Europe Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 29. Europe Pertussis Vaccine Sales Market Share by Country (2019-2030)
Figure 30. Germany Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 31. France Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 32. U.K. Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 33. Italy Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 34. Netherlands Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 35. Asia Pacific Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 36. Asia Pacific Pertussis Vaccine Sales Market Share by Country (2019-2030)
Figure 37. China Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 38. Japan Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 39. South Korea Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 40. Southeast Asia Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 41. India Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 42. Australia Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 43. LAMEA Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 44. LAMEA Pertussis Vaccine Sales Market Share by Country (2019-2030)
Figure 45. Mexico Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 46. Brazil Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 47. Turkey Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 48. GCC Countries Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 49. Global Pertussis Vaccine Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 50. Global Pertussis Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 51. North America Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 52. North America Pertussis Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 53. Europe Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 54. Europe Pertussis Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 55. Asia-Pacific Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 56. Asia-Pacific Pertussis Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 57. LAMEA Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 58. LAMEA Pertussis Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 59. Pertussis Vaccine Value Chain
Figure 60. Manufacturing Cost Structure
Figure 61. Pertussis Vaccine Production Mode & Process
Figure 62. Direct Comparison with Distribution Share
Figure 63. Distributors Profiles
Figure 64. Years Considered
Figure 65. Research Process
Figure 66. Key Executives Interviewed
Figure 1. Pertussis Vaccine Product Picture
Figure 2. Global Pertussis Vaccine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pertussis Vaccine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Pertussis Vaccine Sales (2019-2030) & (M Doses)
Figure 5. Global Pertussis Vaccine Average Price (USD/Doses) & (2019-2030)
Figure 6. Global Top 5 and 10 Pertussis Vaccine Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Whole-cell Vaccines Picture
Figure 9. Acellular Vaccines Picture
Figure 10. Global Pertussis Vaccine Sales by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 11. Global Pertussis Vaccine Sales Market Share 2019 VS 2023 VS 2030
Figure 12. Global Pertussis Vaccine Sales Market Share by Type (2019-2030)
Figure 13. Global Pertussis Vaccine Revenue by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 14. Global Pertussis Vaccine Revenue Market Share 2019 VS 2023 VS 2030
Figure 15. Global Pertussis Vaccine Revenue Market Share by Type (2019-2030)
Figure 16. 12 Months Below Picture
Figure 17. 12 Months Above Picture
Figure 18. Global Pertussis Vaccine Sales by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 19. Global Pertussis Vaccine Sales Market Share 2019 VS 2023 VS 2030
Figure 20. Global Pertussis Vaccine Sales Market Share by Application (2019-2030)
Figure 21. Global Pertussis Vaccine Revenue by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 22. Global Pertussis Vaccine Revenue Market Share 2019 VS 2023 VS 2030
Figure 23. Global Pertussis Vaccine Revenue Market Share by Application (2019-2030)
Figure 24. North America Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 25. North America Pertussis Vaccine Sales Market Share by Country (2019-2030)
Figure 26. U.S. Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 27. Canada Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 28. Europe Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 29. Europe Pertussis Vaccine Sales Market Share by Country (2019-2030)
Figure 30. Germany Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 31. France Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 32. U.K. Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 33. Italy Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 34. Netherlands Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 35. Asia Pacific Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 36. Asia Pacific Pertussis Vaccine Sales Market Share by Country (2019-2030)
Figure 37. China Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 38. Japan Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 39. South Korea Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 40. Southeast Asia Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 41. India Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 42. Australia Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 43. LAMEA Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 44. LAMEA Pertussis Vaccine Sales Market Share by Country (2019-2030)
Figure 45. Mexico Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 46. Brazil Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 47. Turkey Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 48. GCC Countries Pertussis Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 49. Global Pertussis Vaccine Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 50. Global Pertussis Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 51. North America Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 52. North America Pertussis Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 53. Europe Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 54. Europe Pertussis Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 55. Asia-Pacific Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 56. Asia-Pacific Pertussis Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 57. LAMEA Pertussis Vaccine Revenue (2019-2030) & (US$ Million)
Figure 58. LAMEA Pertussis Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 59. Pertussis Vaccine Value Chain
Figure 60. Manufacturing Cost Structure
Figure 61. Pertussis Vaccine Production Mode & Process
Figure 62. Direct Comparison with Distribution Share
Figure 63. Distributors Profiles
Figure 64. Years Considered
Figure 65. Research Process
Figure 66. Key Executives Interviewed
